Drugs interacting with 5-HT systems show promise for treatment of eating disorders
- 28 February 1989
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 10 (2) , 56-57
- https://doi.org/10.1016/0165-6147(89)90076-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- 5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterizationTrends in Neurosciences, 1988
- Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonistsSynapse, 1987
- Medial hypothalamic serotonin: Effects on deprivation and norepinephrine-induced eatingPharmacology Biochemistry and Behavior, 1986
- Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptorsEuropean Journal of Pharmacology, 1986
- Para-chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT)Psychopharmacology, 1986
- Peripheral and central mechanisms of action of serotoninergic anorectic drugsAppetite, 1986
- Serotonin manipulations and the structure of feeding behaviourAppetite, 1986
- Suppression of Eating by Fenfluramine in Patients with Bulimia NervosaThe British Journal of Psychiatry, 1985
- Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the ratPsychopharmacology, 1985